Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA

Osteoporosis International

Volumn 25, Issue 3, 2014, Pages 847-855

  Prieto Alhambra, D ^a,b,i,j   Petri, H ^c   Goldenberg, J S B ^c,d,e   Khong, T P ^c,d   Klungel, O H ^d   Robinson, N J ^f   De Vries, F ^d,g,h  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c ROCHE PRODUCTS LTD   (United Kingdom)

^d UTRECHT UNIVERSITY   (Netherlands)

^e Chemical Design and Synthesis Unit   (Netherlands)

^f Building 663   (Switzerland)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^j INST MUNIC D INVESTIGACIO MEDICA   (Spain)

more..

Author keywords

Antidepressants; Drug utilization; Hip fractures; Pharmacoepidemiology

Indexed keywords

ANTIDEPRESSANT AGENT;

CHEMICALLY INDUCED; DRUG UTILIZATION; EUROPE; HIP FRACTURES; HUMAN; PREVALENCE; PROCEDURES; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ANTIDEPRESSIVE AGENTS; DRUG UTILIZATION; EUROPE; HIP FRACTURES; HUMANS; PREVALENCE; RISK ASSESSMENT; UNITED STATES;

EID: 84894518556     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2612-2     Document Type: Article

References (43)

1. Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7(5):407-413
2. van Staa TP, Dennison EM, Leufkens HG, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29(6):517-522
3. Pagès-Castellà A, Carbonell-Abella C, Avilés FF, Alzamora M, Baena-Díez JM, Laguna DM, Nogués X, Díez-Pérez A, Prieto-Alhambra D (2012) Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study. BMC Musculoskelet Disord 13:79
4. Haentjens P, Lamraski G, Boonen S (2005) Costs and consequences of hip fracture occurrence in old age: an economic perspective. Disabil Rehabil 27(18-19):1129-1141
5. Braithwaite RS, Col NF, Wong JB (2003) Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51(3):364-370
6. Lefauveau P, Fardellone P (2004) Extraskeletal risk factors for fractures of the proximal femur. Joint Bone Spine 71(1):14-17
7. Pharmacovigilance Working Party (PhVWP) (2010) Summary Assessment Report of the PhVWP March 2010 Antidepressants - risk of bone fractures. http://www.ema.europa.eu/docs/en-GB/document-library/Report/2010/04/WC500088721. pdf. Accessed September
8. Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH (2005) Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 146(2):685-693
9. Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM et al (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169(21):1952-1960
10. Verdel BM, Souverein PC, Egberts TC, van Staa TP, Leufkens HG, de Vries F (2010) Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Bone 47(3):604-609
11. IMS Health Retail & Hospital Audits Synopsis (2010) 22nd July 2
12. IMS MIDAS International Data Overview (2005) Basel, 26 October: 37-38
13. IMI PROTECT Study (2011) http://www.imi-protect.eu/. Accessed January
14. Coughlin SS, Benichou J, Weed DL (1994) Attributable risk estimation in case-control studies. Epidemiol Rev 16:51-64
15. The Register of Medicinal of Product Statistics of the Danish Medicines Agency: Statistics on medicinal products, 2005-2009. http://www.dkma.dk. Accessed November 2010
16. The Dutch Drug Information System of the Health Care Insurance Board. http://www.gipdatabank.nl/. Accessed November 2010
17. Norwegian Institute of Public Health. Norwegian Prescription Database. http://www.norpd.no/default.aspx. Accessed November 2010
18. U.S. Census Bureau, Housing and Household Economic Statistics Division. Last revised: September 21, 2009. http://www.census.gov. Accessed on October 2010
19. European Commission, Eurostat. http://epp.eurostat.ec.europa.eu/portal/ page/portal/eurostat/home/>. Accessed October 2010
20. World Health Organization (editor) (2003) Introduction to drug utilization research. Oslo, Norway
21. Macera CA, Powell KE (2001) Population attributtable risk: implications of physical activity dose. Med Sci Sports Exerc 33(6 Suppl):S635-S639, discussion 640-1
22. Guo Z, Wills P, Viitanen M, Fastbom J, Winblad B (1998) Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol 148(9):887-892
23. Jacqmin-Gadda H, Fourrier A, Commenges D, Dartigues JF (1998) Risk factors for fractures in the elderly. Epidemiology 9(4):417-423
24. Ensrud KE, Blackwell T, Mangione CM, Bowman PJ, Bauer DC, Schwartz A et al (2003) Central nervous system active medications and risk for fractures in older women. Arch Intern Med 163(8):949-957
25. Spangler L, Scholes D, Brunner RL, Robbins J, Reed SD, Newton KM et al (2008) Depressive symptoms, bone loss, and fractures in postmenopausal women. J Gen Intern Med 23(5):567-574
26. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ III (1987) Psychotropic drug use and the risk of hip fracture. N Engl J Med 316(7):363-369
27. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N (1998) Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351(9112):1303-1307
28. van den Brand MW, Samson MM, Pouwels S, van Staa TP, Thio B, Cooper C et al (2009) Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int 20(10):1705-1713
29. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J (2001) Zolpidem use and hip fractures in older people. J Am Geriatr Soc 49(12):1685-1690
30. Ray WA, Griffin MR, Malcolm E (1991) Cyclic antidepressants and the risk of hip fracture. Arch Intern Med 151(4):754-756
31. Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A (2003) Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 158(1):77-84
32. Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17(6):807-816
33. Abrahamsen B, Brixen K (2009) Mapping the prescriptiome to fractures in men - a national analysis of prescription history and fracture risk. Osteoporos Int 20(4):585-597
34. Bauer M, Monz BU, Montejo AL, Quail D, Dantchev N, Demyttenaere K et al (2008) Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 23(1):66-73
35. Takkouche B, Montes-Martinez A, Gill SS, Etminan M (2007) Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf 30(2):171-184
36. Haney EM, Warden SJ (2008) Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies. J Musculoskelet Neuronal Interact 8(2):133-145
37. Battaglino R, Fu J, Spate U, Ersoy U, Joe M, Sedaghat L et al (2004) Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res 19(9):1420-1431
38. Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM et al (2007) Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167(12):1240-1245
39. Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC et al (2007) Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167(2):188-194
40. Haney EM, Chan BK, Diem SJ, Ensrud KE, Cauley JA, Barrett-Connor E et al (2007) Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167(12):1246-1251
41. Hernandez JF, Mantel-Teeuwisse AK, van Thiel GJ, Belitser SV, Warmerdam J, de Valk V, Raaijmakers JA, Pieters T (2012) A 10-year analysis of the effects of media coverage of regulatory warnings on antidepressant use in the Netherlands and UK. PLoS One 7(9):e45515
42. Pratt LA, Brody DJ, Gu Q (2011) Antidepressant use in persons aged 12 and over: United States, 2005-2008. NCHS Data Brief 76:1-8
43. Schneeweiss S, Wang PS (2004) Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol 24(6):632-638